HNRNPL is highly expressed in both rectal cancer tumor tissue and NACR resistance group, suggesting that reducing the expression of HNRNPL in LACR may increase the sensitivity of patients to NACR, thus achieving a better prognosis. The gene discussed is HNRNPL; the disease is neoplasm.